Gonadorelin, a synthetic analog of the gonadotropin-releasing hormone (GnRH), has garnered attention for its intriguing ...

IBI3014 is a bispecific ADC targeting TROP2 and PD-L1. Its dual mechanism integrates TROP2-directed tumor killing with PD-L1 ...

SAN FRANCISCO and SUZHOU, China, April 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

The health and wellness industry welcomes Mitolyn as its newest product to attract substantial market interest because of its ...

New laboratory at Polytechnic University to start clinical trials for advanced therapy products after facility is fully ...

New research uncovers that aging activates a new type of stem cell that rapidly produces fat cells, explaining why belly fat often expands in middle age.

Summit Therapeutics' shares dropped 36% after ivonescimab data showed no significant survival benefit. Click to read if SMMT ...

Understanding how cells differentiate during early embryonic development is crucial for advancing regenerative medicine and ...

In a nutshell Scientists discovered a new type of fat cell precursor (CP-A) that appears specifically during middle age, ...

EQS-News: Pentixapharm Holding AG / Key word (s): Conference/Scientific publication Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025 ...